Palladia, Pfizer’s Cancer Drug for Dogs, Approved by FDA

By Jacob Goldstein, The Wall Street Journal Health Blog

In a sign of several things — people’s willingness to spend money on their pets, the promise of targeted therapies for cancer, the drug industry’s push to expand multiple revenue streams — the FDA for the first time approved a cancer drug for dogs.

Palladia, a Pfizer drug, is approved for treating advanced mast cell tumors, a common form of cancer in dogs. In a study of 150 dogs, tumors shrank or disappeared in 43% of those that received the drug, compared with 8% of those who received a placebo. The study didn’t look at whether the drug extended the dogs’ lives, and side effects included vomiting and diharrea, said Cheryl London a vet oncologist at Ohio State who conducted early-stage research on the drug.

Read more here.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

Protected with IP Blacklist CloudIP Blacklist Cloud